期刊文献+

阿霉素作为G-四联体配体对Tca8113细胞影响的研究 被引量:3

The effects of adramycin as guanine-quadruplex ligand on Tca8113 cells
下载PDF
导出
摘要 目的:观察阿霉素作为G-四联体配体对Tca8113细胞端粒酶活性、增殖及凋亡的影响,探讨G-四联体结构生物学功能。方法:通过TRAP法和改良TRAP-G4法,分析阿霉素对Tca8113细胞端粒酶介导的端粒延伸反应的影响。研究分2个实验组进行,用药组培养液含2.5μmol/L阿霉素,非用药组培养液加相应体积生理盐水,细胞培养1、3、5和7d后,利用TRAP法检测其端粒酶活性;流式细胞仪分析其细胞周期和凋亡率,并对2实验组间凋亡率进行t检验;Giemsa染色和SA-β-gal染色观察凋亡和衰老细胞。结果:TRAP和改良TRAP-G4检测表明,阿霉素通过诱导G4形成抑制Tca8113细胞端粒酶介导的端粒延伸反应。在2.5μmol/L阿霉素作用下,Tca8113细胞端粒酶活性在3d后出现降低;用药组细胞增殖受抑制,停滞于G0-G1期和S期;所有观察期内2实验组间细胞凋亡率差异有统计学意义(P<0.05);用药组出现衰老和凋亡细胞。结论:阿霉素诱导G-四联体形成,可抑制Tca8113细胞端粒酶活性,降低其增殖活性,促进衰老和凋亡发生。 PURPOSE: To observe the effects of adramycin as guanine-quadruplex ligand on telomerase activity, proliferation and apoptosis of Tca8113 cells by inducing telomere to form G-quadruplex structure, and to evaluate the biological functions of the structures. METHODS: The influence of adramycin on telomeric extension reaction mediated by telomerase of Tca8113 cells were analyzed by TRAP assay and modified TRAP assay. Two groups were adopted in this study , namely treated group containing 2.5μmol/L Adramycin in the medium and untreated one containing sodium saline. Tca8113 cells in the subsequent experiments were cultured for 1,3,5 and 7days. On indicated day, telomerase activity in Tca8113 cells was evaluated bv TRAP assay; the cell cycle and the apoptotic rates were analyzed by flow cytometry; the apoptotic rate differences between the two groups were analyzed with Student's t test; the senescent and apoptotic cells were observed after senescence-associated-β-galactosidase staining and Giemsa staining, respectively. RESULTS: The results of TRAP assay and modified TRAP assay demonstrated that Adramycin led to inhibition of telomeric extension reaction mediated by telomerase of TcaS113 cells by inducing formation of G-quadruplex structures. In the presence of Adramycin at 2.5μmol/L, telomerase activity of Tca8113 cells decreased after 3 days of treatment with adramycin ; cell proliferation of the treated groups was inhibited and the cell cycle arrested at phase G0-G1 and S; there was significant difference of apoptotic rates between the treated group and the untreated one on the indicated day (P〈0.05); Senescent cells and apoptotic cells appeared in the treated groups. CONCLUSIONS: Adramycin's inducing telomere to form G- quadruplex structure lead to inhibition of telomerase activity in Tca8113 cells, decreasing of proliferative activity and occurrence of senescence and apoptosis.
出处 《中国口腔颌面外科杂志》 CAS 2005年第3期212-217,共6页 China Journal of Oral and Maxillofacial Surgery
基金 中国博士后基金(中博基2003033421)
关键词 阿霉素 G-四联体 TCA8113细胞 端粒酶 凋亡 Adramycin Guanine-quadruplex Tca8113 cells Telomerase Apoptosis
  • 相关文献

参考文献6

  • 1[1]Han H, Hurley LH. G-quadruplex DNA: a potential target for anti-cancer drug design[J] . Trends Pharm Sci, 2000,21(4):136-142. 被引量:1
  • 2[2]Riou JF, Guittat L, Mailliet P, et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands[J]. Proc Natl Acad Sci USA, 2002,99(5):2672-2677. 被引量:1
  • 3杨新颖,倪沛洲,陆涛.蒽二酮类抗肿瘤药物的研究进展[J].药学进展,2002,26(5):261-265. 被引量:5
  • 4[4]Gomez D, Mergny JL, Riou JF. Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay[J]. Cancer Res, 2002,62(15):3365-3368. 被引量:1
  • 5[5]Ying L, Green JJ, Li H, et al. Studies on the structure and dynamics of the human telomeric G-quadruplex by singlemolecule fluorescence resonance energy transfer [J]. Proc Natl Acad Sci USA,2003,100(25): 14629-14634. 被引量:1
  • 6[6]Izbicka E, Wheelhouse RT, Raymond E, et al. Effects of cationic Porphyrins as G-quadruplex interactive agents in human tumor cells[J]. Cancer Res, 1999, 59(3):639-644. 被引量:1

二级参考文献22

  • 1[1]Hortobagy G N. Anthracyclines in the treatment of cancer [J]. Drugs suppl,1997,54:1-7. 被引量:1
  • 2[2]Arcamone F M. From the pigment of actinomycetes to third generation antitumor anthracyclines[J]. Biochimie,1998,80:201-206. 被引量:1
  • 3[3]Barasch D, Zipori O, Ringel I,et al. Novel anthraquinone derivatives with redox-active functional groups capable of producing free radicals by metabolism: are free radicals essential for cytotoxicity[J]. Eur J Med Chem,1999,34:597-615. 被引量:1
  • 4[4]Malonne H, Atassi G. DNA topoisomerase targeting drugs:Mechanism of action and perspectives[J]. Anticancer Drug,1997,8:811-822. 被引量:1
  • 5[5]Zagotto G, Supino R, Favivini E,et al. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents[J]. Farmaco,2000,55:1-5. 被引量:1
  • 6[6]Perry P J, Gowan S M, Reszka A P, et al. 1,4-and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase[J].J Med Chem,1998,41:3253-3260. 被引量:1
  • 7[7]Krapcho P A,Menta E,Antitumor aza-anthrapyrazoles[J].Drugs Fut,1997,22(6):641-646. 被引量:1
  • 8[8]Monneret C. Recent developments in the field of antitumour anthracyclines[J]. Eur J Med Chem,2001,36:483-493. 被引量:1
  • 9[9]biantrazole [J].Drugs Fut,1989,14:742. 被引量:1
  • 10[10]Showalter H D, Johnson J L,Hoftiezer J M, et al. Anthrapyrazole anticancer agents. Synthesis and structure-activity relation against murine leukemias[J]. J Med Chem,1987,30:121-31. 被引量:1

共引文献4

同被引文献20

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部